Literature DB >> 22110277

Fascin promotes the motility and invasiveness of pancreatic cancer cells.

Yan-Feng Xu1, Shuang-Ni Yu, Zhao-Hui Lu, Jian-Ping Liu, Jie Chen.   

Abstract

AIM: To explore the role of actin-bundling protein, fascin during the progression of pancreatic cancer.
METHODS: The plasmid expressing human fascin-1 was stably transfected into the pancreatic cancer cell line MIA PaCa-2. The proliferation, cell cycle, motility, scattering, invasiveness and organization of the actin filament system in fascin-transfected MIA PaCa-2 cells and control non-transfected cells were determined.
RESULTS: Heterogeneous overexpression of fascin markedly enhanced the motility, scattering, and invasiveness of MIA PaCa-2 cells. However, overexpression of fascin had minimal effect on MIA PaCa-2 cell proliferation and cell cycle. In addition, cell morphology and organization of the actin filament system were distinctly altered in fascin overexpressed cells. When transplanted into BALB/c-nu mice, fascin-transfected pancreatic cancer cells developed solid tumors at a slightly slower rate, but these tumors displayed more aggressive behavior in comparison with control tumors.
CONCLUSION: Fascin promotes pancreatic cancer cell migration, invasion and scattering, thus contributes to the aggressive behavior of pancreatic cancer cells.

Entities:  

Keywords:  Fascin; Invasiveness; Motility; Pancreatic cancer

Mesh:

Substances:

Year:  2011        PMID: 22110277      PMCID: PMC3218137          DOI: 10.3748/wjg.v17.i40.4470

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?

Authors:  Yosuke Hashimoto; Marek Skacel; Josephine C Adams
Journal:  Int J Biochem Cell Biol       Date:  2005-09       Impact factor: 5.085

2.  C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.

Authors:  A Grothey; R Hashizume; H Ji; B E Tubb; C W Patrick; D Yu; E E Mooney; P D McCrea
Journal:  Oncogene       Date:  2000-10-05       Impact factor: 9.867

3.  Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.

Authors:  Anirban Maitra; Christine Iacobuzio-Donahue; Ayman Rahman; Taylor A Sohn; Peter Argani; Renee Meyer; Charles J Yeo; John L Cameron; Michael Goggins; Scott E Kern; Raheela Ashfaq; Ralph H Hruban; Robb E Wilentz
Journal:  Am J Clin Pathol       Date:  2002-07       Impact factor: 2.493

4.  Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.

Authors:  Anirban Maitra; N Volkan Adsay; Pedram Argani; Christine Iacobuzio-Donahue; Angelo De Marzo; John L Cameron; Charles J Yeo; Ralph H Hruban
Journal:  Mod Pathol       Date:  2003-09       Impact factor: 7.842

5.  A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.

Authors:  Bence Sipos; Simone Möser; Holger Kalthoff; Virag Török; Matthias Löhr; Günter Klöppel
Journal:  Virchows Arch       Date:  2003-04-12       Impact factor: 4.064

6.  Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.

Authors:  Sharon L Swierczynski; Anirban Maitra; Susan C Abraham; Christine A Iacobuzio-Donahue; Raheela Ashfaq; John L Cameron; Richard D Schulick; Charles J Yeo; Ayman Rahman; David A Hinkle; Ralph H Hruban; Pedram Argani
Journal:  Hum Pathol       Date:  2004-03       Impact factor: 3.466

7.  Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

Authors:  Ajay P Singh; Nicolas Moniaux; Subhash C Chauhan; Jane L Meza; Surinder K Batra
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

8.  Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

Authors:  Christine A Iacobuzio-Donahue; Raheela Ashfaq; Anirban Maitra; N Volkan Adsay; Grace L Shen-Ong; Karin Berg; Michael A Hollingsworth; John L Cameron; Charles J Yeo; Scott E Kern; Michael Goggins; Ralph H Hruban
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

9.  Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro.

Authors:  Aida U Jawhari; Andrea Buda; Michelle Jenkins; Khurram Shehzad; Catherine Sarraf; Masao Noda; Michael J G Farthing; Massimo Pignatelli; Josephine C Adams
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

10.  Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer.

Authors:  G Pelosi; U Pastorino; F Pasini; P Maissoneuve; F Fraggetta; A Iannucci; A Sonzogni; G De Manzoni; A Terzi; E Durante; E Bresaola; F Pezzella; G Viale
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640

View more
  8 in total

1.  Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.

Authors:  Syreeta L Tilghman; Ian Townley; Qiu Zhong; Patrick P Carriere; Jin Zou; Shawn D Llopis; Lynez C Preyan; Christopher C Williams; Elena Skripnikova; Melyssa R Bratton; Qiang Zhang; Guangdi Wang
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

2.  Fascin1 mediated release of pro-inflammatory cytokines and invasion/migration in rheumatoid arthritis via the STAT3 pathway.

Authors:  Kun Ma; Chuan Zhang; Wuyin Li
Journal:  Cell Cycle       Date:  2021-09-09       Impact factor: 5.173

Review 3.  Actin binding proteins: their ups and downs in metastatic life.

Authors:  Stephane R Gross
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

4.  Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma.

Authors:  Banu Dogan Gun; Burak Bahadir; Sibel Bektas; Figen Barut; Gamze Yurdakan; Nilufer Onak Kandemir; Sukru Oguz Ozdamar
Journal:  Diagn Pathol       Date:  2012-07-11       Impact factor: 2.644

5.  Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer.

Authors:  Xiao-Ling Ling; Tao Zhang; Xiao-Ming Hou; Da Zhao
Journal:  Onco Targets Ther       Date:  2015-06-30       Impact factor: 4.147

6.  Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.

Authors:  Priscila Campioni Rodrigues; Iris Sawazaki-Calone; Carine Ervolino de Oliveira; Carolina Carneiro Soares Macedo; Mauricio Rocha Dourado; Nilva K Cervigne; Marcia Costa Miguel; Andreia Ferreira do Carmo; Daniel W Lambert; Edgard Graner; Sabrina Daniela da Silva; Moulay A Alaoui-Jamali; Adriana Franco Paes Leme; Tuula A Salo; Ricardo D Coletta
Journal:  Oncotarget       Date:  2017-08-19

7.  High Expression Levels of Fascin-1 Protein in Human Gliomas and its Clinical Relevance.

Authors:  Hao Zhang; Qing-Xue Cong; Shan-Guo Zhang; Xiu-Wei Zhai; Hui-Feng Li; Shuang-Qi Li
Journal:  Open Med (Wars)       Date:  2018-10-25

8.  Fascin promotes the invasion of pituitary adenoma through partial dependence on epithelial-mesenchymal transition.

Authors:  Hong You; Jian Xu; Xiaochun Qin; Guodong Qian; Yang Wang; Fulei Chen; Xiaoxu Shen; Dong Zhao; Qi Liu
Journal:  J Mol Histol       Date:  2021-06-07       Impact factor: 2.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.